A Randomized, Double-blind, Placebo-controlled, Sequential Parallel Group, SAD/MAD Study Following Oral Administration in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MT2004
This is a randomized, double-blind, placebo-controlled, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a single dose of MT2004 following oral single and multiple ascending dose administration.
100 项与 西安必康制药集团有限公司 相关的临床结果
0 项与 西安必康制药集团有限公司 相关的专利(医药)
100 项与 西安必康制药集团有限公司 相关的药物交易
100 项与 西安必康制药集团有限公司 相关的转化医学